+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoporosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Osteoporosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Sale

Osteoporosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • June 2025
  • Region: Global
  • TechSci Research
  • ID: 5306204
UP TO OFF until Jul 31st 2025
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Osteoporosis Drugs Market was valued at USD 13.40 Billion in 2024, and is expected to reach USD 16.91 Billion by 2030, rising at a CAGR of 4.15%. Osteoporosis, a progressive skeletal disorder marked by low bone mass and heightened fracture risk, predominantly affects postmenopausal women and the elderly. As global life expectancy rises, so too does the prevalence of osteoporosis and associated fractures, driving strong demand for pharmacological therapies.

The market spans various drug categories, including bisphosphonates, SERMs, RANK ligand inhibitors, calcitonin, and parathyroid hormone analogs. Bisphosphonates, such as alendronate and risedronate, have historically dominated due to their affordability and widespread clinical use. While the market outlook remains favorable, challenges such as high costs associated with newer biologic treatments, concerns regarding long-term side effects, and adherence issues continue to temper broader adoption.

Key Market Drivers

Growth in Healthcare Industry

The global healthcare sector’s continued growth plays a pivotal role in advancing the osteoporosis drugs market. With annual sales surpassing USD 4 trillion, key healthcare segments include pharmaceuticals and biotechnology, generating nearly USD 850 billion, and medical diagnostics and technology, contributing over USD 400 billion. As healthcare infrastructure expands and access improves worldwide, there is a heightened focus on early detection and effective treatment of chronic age-related conditions like osteoporosis. This rising awareness and investment are translating into increased demand for medications aimed at enhancing bone density and minimizing fracture risk.

Key Market Challenges

High Cost of Therapy

The substantial cost of osteoporosis therapy presents a major barrier to widespread access, particularly in lower-income and underinsured populations. Although biologics such as denosumab and parathyroid hormone analogs like teriparatide offer strong efficacy for high-risk patients, these treatments are priced significantly higher than conventional options like bisphosphonates. This pricing disparity limits affordability, especially in regions where public healthcare systems are underfunded or health insurance coverage is insufficient. The long-term nature of osteoporosis treatment further intensifies the economic burden for patients and providers alike.

Key Market Trends

Rise in Home-Based Osteoporosis Care

The growing shift toward home-based osteoporosis management is reshaping the landscape of care delivery. In May 2023, the International Osteoporosis Foundation (IOF) launched the Build Better Bones platform - a digital resource designed to support individuals and caregivers with practical tools for strengthening bones and preventing fragility fractures. This trend reflects a broader move toward patient-centric care models, particularly for elderly or mobility-limited patients.

By facilitating remote education, personalized exercise routines, and nutritional guidance, home-based care helps improve adherence to long-term drug regimens and enhances clinical outcomes. It also reduces pressure on healthcare facilities, offering a more accessible and cost-effective approach to chronic disease management.

Key Market Players

  • Eli Lilly and Company
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc.
  • Novartis International AG
  • Merck & Co. Inc.
  • Amgen Inc.
  • Radius Health Inc.
  • Actavis PLC

Report Scope

In this report, the Global Osteoporosis Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Osteoporosis Drugs Market, By Route of Administration:

  • Oral
  • Injectables
  • Others

Osteoporosis Drugs Market, By Drug Type:

  • Parathyroid Hormone Therapy
  • Bisphosphonates
  • Calcitonin
  • Selective Estrogen Receptor Modulators
  • Others

Osteoporosis Drugs Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Osteoporosis Drugs Market.

Available Customizations

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Osteoporosis Drugs Market
5. Global Osteoporosis Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Route of Administration (Oral, Injectables, Others)
5.2.2. By Drug Type (Parathyroid Hormone Therapy, Bisphosphonates, Calcitonin, Selective Estrogen Receptor Modulators, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Osteoporosis Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Route of Administration
6.2.2. By Drug Type
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Osteoporosis Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Route of Administration
6.3.1.2.2. By Drug Type
6.3.2. Mexico Osteoporosis Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Route of Administration
6.3.2.2.2. By Drug Type
6.3.3. Canada Osteoporosis Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Route of Administration
6.3.3.2.2. By Drug Type
7. Europe Osteoporosis Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Drug Type
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Osteoporosis Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Route of Administration
7.3.1.2.2. By Drug Type
7.3.2. Germany Osteoporosis Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Route of Administration
7.3.2.2.2. By Drug Type
7.3.3. United Kingdom Osteoporosis Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Route of Administration
7.3.3.2.2. By Drug Type
7.3.4. Italy Osteoporosis Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Route of Administration
7.3.4.2.2. By Drug Type
7.3.5. Spain Osteoporosis Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Route of Administration
7.3.5.2.2. By Drug Type
8. Asia Pacific Osteoporosis Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Route of Administration
8.2.2. By Drug Type
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Osteoporosis Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Route of Administration
8.3.1.2.2. By Drug Type
8.3.2. India Osteoporosis Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Route of Administration
8.3.2.2.2. By Drug Type
8.3.3. South Korea Osteoporosis Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Route of Administration
8.3.3.2.2. By Drug Type
8.3.4. Japan Osteoporosis Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Route of Administration
8.3.4.2.2. By Drug Type
8.3.5. Australia Osteoporosis Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Route of Administration
8.3.5.2.2. By Drug Type
9. South America Osteoporosis Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Route of Administration
9.2.2. By Drug Type
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Osteoporosis Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Route of Administration
9.3.1.2.2. By Drug Type
9.3.2. Argentina Osteoporosis Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Route of Administration
9.3.2.2.2. By Drug Type
9.3.3. Colombia Osteoporosis Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Route of Administration
9.3.3.2.2. By Drug Type
10. Middle East and Africa Osteoporosis Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Route of Administration
10.2.2. By Drug Type
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Osteoporosis Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Route of Administration
10.3.1.2.2. By Drug Type
10.3.2. Saudi Arabia Osteoporosis Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Route of Administration
10.3.2.2.2. By Drug Type
10.3.3. UAE Osteoporosis Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Route of Administration
10.3.3.2.2. By Drug Type
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions : Conflicts, Pandemics and Trade Barriers14. Global Osteoporosis Drugs Market: SWOT Analysis
15. Porters Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Eli Lilly and Company
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. Pfizer Inc.
16.3. F. Hoffmann-La Roche Ltd
16.4. Teva Pharmaceutical Industries Ltd.
16.5. GlaxoSmithKline plc.
16.6. Novartis International AG
16.7. Merck & Co. Inc.
16.8. Amgen Inc.
16.9. Radius Health Inc.
16.10. Actavis PLC
17. Strategic Recommendations18. About the Publisher & Disclaimer

Companies Mentioned

  • Eli Lilly and Company
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc.
  • Novartis International AG
  • Merck & Co. Inc.
  • Amgen Inc.
  • Radius Health Inc.
  • Actavis PLC

Table Information

Report AttributeDetails
No. of Pages185
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 13.4 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.91 Billion
Compound Annual Growth Rate4.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Anti Osteoporosis Therapy and Fracture Healing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Anti Osteoporosis Therapy and Fracture Healing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Osteoporosis Treatment Market Report 2025 - Product Image

Osteoporosis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Osteoporosis Drugs Market by Drug Class, Route of Administration, Dosage Form, Distribution Channel, End User, Patient Gender - Global Forecast to 2030 - Product Image

Osteoporosis Drugs Market by Drug Class, Route of Administration, Dosage Form, Distribution Channel, End User, Patient Gender - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Osteoporosis Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Osteoporosis Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Osteoporosis Drugs Market Report 2025 - Product Image

Osteoporosis Drugs Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.